You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

EVENTS

World Hemophilia Day 2021, Kedrion alongside patients

Today, more than ever, the company is close to those who are in a vulnerable condition

read more 

PLASMA & BIOTHERAPIES

Rh&Life, first subject included in the study

Two hundred pregnant women to be enrolled over five countries

read more 

PLASMA & BIOTHERAPIES

KIDCARES10, first patient enrolled in pediatric PI study

Thirty patients aged 2 to 17 years old to be enrolled over five European countries

read more 
  1. CORPORATE - 28-07-2020

    Kedrion’s Mother and Child Health campaign for Asia and MEA announced

    Details were unveiled during our first televised Regional Distributor Meeting on July 14th-15th

    read more 
  2. CORPORATE - 21-07-2020

    COVID-19. Kedrion partners with Columbia University Irving MC

    Kedrion and Columbia University release video statements

    read more 
  3. EVENTS - 11-07-2020

    ISTH, Kedrion supports symposium on the importance of inhibitor eradication

    The central theme of the round table will be the optimization of the treatment of patients with Hemophilia A

    read more 

Pages

For more information please contact: [email protected]